Soulaire Corporation

Soulaire Corporation manufactures FDA-cleared Enhanced External Counterpulsation (EECP) circulation enhancement devices for non-surgical cardiovascular wellness, disease prevention, and anti-aging applications. The proprietary system uses sequential pneumatic compression cuffs applied to the calves, thighs, and buttocks, synchronized with patient heartbeat to augment diastolic pressure and promote collateral artery development. Indicated for cardiac conditions including congestive heart failure, angina, coronary artery disease, and peripheral artery disease, as well as stroke recovery, renal dysfunction, diabetes management, and erectile dysfunction. Clinical applications extend to systemic circulation improvement affecting multiple organ systems, lymphatic function, and metabolic health. Distributed exclusively by Soulaire with headquarters in Santa Monica, California.